BMEA - Biomea Fusion, Inc.

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-81,828
-81,828
-41,567
-5,324
-1,198
Depreciation & amortisation
691
691
249
8
0
Stock-based compensation
10,336
10,336
6,234
322
0
Change in working capital
7,669
7,669
-1,574
411
-81
Accounts payable
2,960
2,960
640
418
-98
Other working capital
-63,447
-63,447
-38,609
-4,510
-1,279
Other non-cash items
571
571
704
124
-
Net cash provided by operating activities
-62,417
-62,417
-35,438
-4,459
-1,279
Cash flows from investing activities
Investments in property, plant and equipment
-1,030
-1,030
-3,171
-51
-
Purchases of investments
0
0
-38,492
-
0
Sales/maturities of investments
28,371
28,371
8,308
-
0
Net cash used for investing activities
27,341
27,341
-33,355
-51
0
Cash flows from financing activities
Common stock issued
0
0
152,753
10,192
1,440
Net cash used provided by (used for) financing activities
1,239
1,239
153,185
65,966
1,440
Net change in cash
-33,837
-33,837
84,392
61,456
161
Cash at beginning of period
146,087
146,087
61,695
239
78
Cash at end of period
112,250
112,250
146,087
61,695
239
Free cash flow
Operating cash flow
-62,417
-62,417
-35,438
-4,459
-1,279
Capital expenditure
-1,030
-1,030
-3,171
-51
-
Free cash flow
-63,447
-63,447
-38,609
-4,510
-1,279